Keyphrases
B-cell non-Hodgkin Lymphoma (B-NHL)
14%
Chromosomal Translocation
14%
Clinical Course
14%
Clinical Trials
14%
Curative Treatment
14%
Cyclin D1 (CCND1)
14%
Extranodal
14%
Highly Active
14%
Investigational Agents
14%
Line of Therapy
14%
Lymphomagenesis
14%
Mantle Cell Lymphoma
100%
Novel Therapeutic Targets
14%
Ongoing Clinical Trials
14%
Overall Outcome
14%
Overexpression
14%
Previously Untreated Patients
14%
Recent Advances
100%
Standard of Care
14%
Subsequent Line
14%
Medicine and Dentistry
B Cell
14%
Chromosome Translocation
14%
Clinical Trial
28%
Cyclin D1
14%
Disease Course
14%
Immunotherapy
14%
Mantle Cell Lymphoma
100%
Non-Hodgkin Lymphoma
14%
Pharmacology, Toxicology and Pharmaceutical Science
Chromosome Translocation
14%
Clinical Trial
28%
Cyclin D1
14%
Disease Course
14%
Immunotherapy
14%
Mantle Cell Lymphoma
100%
Molecular Target
14%
Nonhodgkin Lymphoma
14%